Best in Biotech 4 Nov 2022
Get to know 15 of the best biotech companies in Paris
Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In this guide, we explore 15…
Cellectis
- Latest Posts
News and Trends 22 Oct 2021
Gene-Edited T Cell Therapy Players Battle Safety Doubts
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused all clinical development following the…
In Depth 11 Oct 2021
A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this ‘miraculous technology’ and what can…
News and Trends 23 Feb 2021
European Cancer Deals Increasingly Focus on Natural Killer Cells
Natural killer cells are becoming a hot topic in the booming cancer cell therapy scene, with the field’s latest big…
ADVERTISEMENT
News and Trends 17 Dec 2020
Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American Society of Hematology (ASH) displayed…
News and Trends 14 Nov 2019
Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential
An off-the-shelf, gene edited CAR T-cell therapy, developed by the French biotech Cellectis, could be used to tackle solid tumors,…
News and Trends 13 Jun 2018
French Biotech Develops a New Generation of Safer CAR-T Cells
Cellectis is developing a new type of chimeric antigen receptor that could improve the production and safety of CAR-T cell…
News and Trends 11 Apr 2018
French CAR-T Developer Raises $164M Despite a Challenging Road
Cellectis has raised $164M (€132M) in a follow-on offering to further develop its CAR-T technology in clinical trials, despite having mixed…
In Depth 13 Mar 2018
The Most Important Battle in Gene Editing: CRISPR versus TALEN
Despite all the hype, CRISPR is still not in the clinic as a standalone therapy or part of another. So…
News and Trends 16 Feb 2018
French Biotech Gets a CRISPR Patent for CAR-T Research
Update (16/02/2018): On top of the European patent it got last July, Cellectis now also has two US patents to…
ADVERTISEMENT
News and Trends 23 Jan 2018
Another Huge Acquisition Sees CAR-T Stocks Jump – Except for Celyad
Most CAR-T stocks rose on the news that Big Biotech Celgene has plans to acquire Juno: Cellectis rides the wave…
In Depth 17 Jan 2018
An Update on What’s New in the French Biotech Industry
Here's a closer look at the French biotech ecosystem in 2017, which remains one the leading industries in Europe along…
Best in Biotech 27 Dec 2017
The Biggest Biotech News of 2017: What Happened This Year?
Still catching up on news? We've picked out the most exciting things that happened besides clinical results and finance. Here's…
News and Trends 13 Dec 2017
Off-the-Shelf CAR-T Cells Struggle to Improve Cancer Treatment
Data presented at ASH 2017 shows that Servier and Pfizer's UCART19, an allogeneic CAR-T therapy originally developed by Cellectis, might…
In Depth 13 Dec 2017
How Biotech Could Change Your Christmas Dinner
Turkey, roast potatoes, gravy, pigs in blankets... For me, food is an essential part of Christmas. But, biotechs are working…
News and Trends 29 Aug 2017
Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks
European CAR-T stocks have jumped following Gilead’s announcement that it will acquire Kite Pharma, Novartis’ main competitor to launch the…
ADVERTISEMENT
News and Trends 28 Jun 2017
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic
Update (28/06/2017): Cellectis has announced the first administration of UCART123 in its Phase I trial in Acute Myeloid Leukemia. Update…
In Depth 13 Jun 2017
Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?
In the US, the first CRISPR-edited crops were able to bypass GMO regulations, but Europe's plant scientists are still awaiting…
Interview 20 Apr 2017
Which EU Immuno-Oncology Company are you Cheering for?
Immuno-oncology represents a huge breakthrough towards the search for a cancer cure. Biotechs all around Europe are developing innovative ways…
News and Trends 6 Apr 2017
How is Biotech Transforming Pharma’s R&D Model?
Since the early 2000s, pharma has undergone a major reorganization. What roles do strategic alliances and acquisitions play in this…